HomeVeristat

Veristat

Veristat Congratulates TESARO on the FDA Approval of ZEJULA™

Editors Note:  ZEJULA™ is a trademark of TESARO, Inc.   Veristat, a full service Clinical Research Organization (CRO), congratulates TESARO, Inc. on the approval of ZEJULA™. TESARO’s novel oncology therapy niraparib (trade name, ZEJULA™) was approved on March...